1Krolewski M,Eggers P,Warram J H,et al. Magnitude of Endstage Renal Disease in IDDM: a 35 Year Follow-up Study[J]. Kidney Int, 1996,50 : 2041-2046.
2Strojek K, Grzeszczak W, Morawin E, et al. Nephropathy of Type Ⅱ Diabetes:Evidence for Hereditary Factors? [J]. Kidney Int, 1997,51 : 1602-1607.
3Pettitt D J, Saad M F, Bennett P H, et al. Familial Predisposition to Renal Disease in two Generations of Pima Indians with Type2 (Non-insulin-dependent)Diabetes Mellitus[J]. Diabetologia,1990,33:438-443.
4Ng D P, Tai B C, Koh D, et al. Angiotensin-Ⅰ Converting Enzyme Insertion/Deletion Polymorphism and Its Association with Diabetic Nephropathy: a Meta-analysis of Studies Reported Between 1994 and 2004 and Comprising 14 727 Subjects [J]. Diabetologia, 2005,48: 1008-1016.
5Rosenbery M,Correa-Rottar R. Pathogenesis and Risk Factor for Diabetic Nephropathy[J]. Kidney Int, 2003,17 (46) : 272.
6Tada H, Isogai S. The Fibronectin Production is Increased by Thrombospondin Via Activation of TGF-bete in Cultured Human Mesangial Cells[J]. Nephron,1998,79(1) :38-43.
7Cortes P,Zhao X,Riser B L,et al. Role of Glomerular Mechanical Strain in the Pathogenesis of Diabetic Nephropathy[J]. Kidney Int,1997,51(1):57-58.
8Boyd-white J, Williams J C. Effect of Cross-linking in Matrix Permeability:a Model for AGE-modified Basement Membranes [J]. Diabetes, 1996,45 : 348.
9Fukami K, Ueda S, Yamagishi S, et al. AGEs Activate Mesangial TGF-heta-Smad Signaling Via an Angiotensin Ⅱ Type Ⅰ Receptor Interaction[J]. Kidney Int, 2004,66 : 2137-2147.
10Hoshi S, Shu Y, Yoshida F, et al. Podocyte Injury Promotes Progressive Nephropathy in Zucker Diabetic Fatty Rats[J]. Lab invest,2002,82(1):25-35.
